Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials (Neuropsychopharmacology, (2020), 45, 5, (887-901), 10.1038/s41386-019-0573-7)

Hideaki Tani, Shotaro Takasu, Hiroyuki Uchida, Takefumi Suzuki, Masaru Mimura, Hiroyoshi Takeuchi

Research output: Contribution to journalComment/debate

Abstract

In the original version of this Article, the DOI doi.org/10.1016/j. schres.2019.09.013 was incorrectly listed for reference 9. It should instead be listed for reference 10. This has been corrected in both the PDF and HTML versions of the Article.

Original languageEnglish
Number of pages1
JournalNeuropsychopharmacology
Volume45
Issue number5
DOIs
Publication statusPublished - 2020 Apr 1

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Correction: Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials (Neuropsychopharmacology, (2020), 45, 5, (887-901), 10.1038/s41386-019-0573-7)'. Together they form a unique fingerprint.

  • Cite this